DANIELLE CAVALIER: Open Payments
NPI 1205476017 · PAINCOURTVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$336 in 11 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $139 · 2025 $336
Food & beverage: $336
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $163 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| PFIZER INC. | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: QULIPTA, ELIQUIS, SCEMBLIX, KISQALI, NINLARO, Enhertu, UBRELVY, CAPLYTA.
Industry payments across LA — which companies pay providers there.
